Skin prick test response to enzyme enolase of the baker's yeast (Saccharomyces cerevisiae) in diagnosis of respiratory allergy.Marita Nittner-Marszalska, Irena Wójcicka-Kustrzeba, Ewa Bogacka, Janusz Patkowski, Rafał Dobek
Med Sci Monit 2001; 7(1): CR121-124 :: ID: 421176
BACKGROUND: The aim of the study is to prove that Saccharomyces cerevisiaeenolase, the major allergen of the baker's yeast, induces allergic immediate response in patients withinhalant allergy sensitized to Candida albicans extract.
MATERIAL AND METHODS: The study was performedin three groups of patients: I. 20 atopic patients with respiratory allergy sensitized to Candida albicansand inhalant allergens (mite, feather, pollens) II. 30 patients with respiratory allergy, positive skintests to inhalant allergens but negative skin tests to Candida albicans and other fungi; III. 20 nonatopic,healthy individuals. Skin prick test of purified enolase from Saccharomyces cerevisiae (bakers yeast)at concentration 1 and 10 mg/ml was performed in all groups. The results were documented planimetrically.
RESULTS: 95% of patients sensitized to Candida albicans extract showed positive skin reactions to Saccharomycescerevisiae enolase, 10% of patients of group II and none of the patients of the control group had positiveskin responses to enolase. The mean wheal size (mm2) in skin prick test to Candida albicans, Saccharomycescerevisiae enolase at concentration 10 mg/ml was x = 15.17 +/- 11.08, 15.76 +/- 19.67 and at concentration1 mg/ml 10.02 +/- 10.49, respectively.
CONCLUSIONS: 1. Saccharomyces cerevisiae enolase induces an immediateallergic reaction in skin in subjects with respiratory allergy and positive skin prick test results toCandida albicans and other fungi. 2. Enolase can be an important allergenic component of the Candidaalbicans extract.
Keywords: fungal allergy, Saccharomyces cerevisiae enolase, baker's yeast enolase
01 May 2022 : EditorialEditorial: Cardiovascular Complications at One Year After SARS-CoV-2 Infection are Independent of Underlying Cardiovascular Risk Factors or Severity of COVID-19
Med Sci Monit 2022; 28:e937048
16 May 2022 : Clinical ResearchImportance of Influenza Anti-Hemagglutinin Antibodies During the SARS-CoV-2 Pandemic in the 2019/2020 Epide...
Med Sci Monit In Press; DOI: 10.12659/MSM.936495
04 May 2022 : Clinical ResearchEffects of Wearing Face Masks on Exercise Capacity and Ventilatory Anaerobic Threshold in Healthy Subjects ...
Med Sci Monit In Press; DOI: 10.12659/MSM.936069
22 April 2022 : Clinical ResearchFactors Associated with Falls During Hospitalization for Coronavirus Disease 2019 (COVID-19)
Med Sci Monit In Press; DOI: 10.12659/MSM.936547
18 May 2022 : Clinical ResearchPhysical and Psychosocial Concept Domains Related to Health-Related Quality of Life (HRQL) in 50 Girls and ...
Med Sci Monit In Press; DOI: 10.12659/MSM.936801
18 May 2022 : Clinical ResearchAssociation Between Variants of the Mannose-Binding Lectin 2 Gene and Susceptibility to Sepsis in the Haina...
Med Sci Monit In Press; DOI: 10.12659/MSM.936134
17 May 2022 : Clinical ResearchClinical Application of C-TIRADS Category and Contrast-Enhanced Ultrasound in Differential Diagnosis of Sol...
Med Sci Monit In Press; DOI: 10.12659/MSM.936368
Most Viewed Current Articles
30 Dec 2021 : Clinical ResearchRetrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...
Med Sci Monit 2021; 27:e935379
08 Mar 2022 : Review articleA Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...
Med Sci Monit 2022; 28:e936292
01 Nov 2020 : Review articleLong-Term Respiratory and Neurological Sequelae of COVID-19
Med Sci Monit 2020; 26:e928996